Literature DB >> 29337418

Specific Noncovalent Interactions Determine Optimal Structure of a Buried Ligand Moiety: QM/MM and Pure QM Modeling of Complexes of the Small-Molecule CD4 Mimetics and HIV-1 gp120.

Francesca Moraca1, David Rinaldo2, Amos B Smith3, Cameron F Abrams4.   

Abstract

The small-molecule CD4 mimetics (smCD4mcs) are a class of highly potent HIV-1 entry inhibitors characterized by a unique structure-activity relationship (SAR). They share a halogenated phenyl ring (region 1) that deeply inserts into an otherwise water-filled cavity at the CD4 binding site on the gp120 surface, the so-called F43 cavity. Conservative modifications to region 1 away from this halogenated phenyl motif have all led to loss of activity, despite the fact that they are predicted by standard empirical computational approaches to bind equally well, making it difficult to further optimize this region of the compounds to increase binding to gp120. In this study we used quantum mechanical methods to understand the roots of the interactions between region 1 and the F43 cavity. We clearly demonstrate the presence of halogen bond/σ-hole and dispersion interactions between region 1 and the F43 cavity residues F376-N377, which are not captured by standard molecular mechanics approaches and the role played by the smCD4mc in the F43 cavity desolvation. These findings rationalize why the halogenated region 1 has proven so difficult to move beyond in smCD4mc optimization, in agreement with experimental evidence.
© 2018 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  HIV-1; QM/MM; gp120 inhibitors; small-molecule CD4 mimetics

Mesh:

Substances:

Year:  2018        PMID: 29337418      PMCID: PMC5901908          DOI: 10.1002/cmdc.201700728

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  24 in total

1.  Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening.

Authors:  Thomas A Halgren; Robert B Murphy; Richard A Friesner; Hege S Beard; Leah L Frye; W Thomas Pollard; Jay L Banks
Journal:  J Med Chem       Date:  2004-03-25       Impact factor: 7.446

2.  Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy.

Authors:  Richard A Friesner; Jay L Banks; Robert B Murphy; Thomas A Halgren; Jasna J Klicic; Daniel T Mainz; Matthew P Repasky; Eric H Knoll; Mee Shelley; Jason K Perry; David E Shaw; Perry Francis; Peter S Shenkin
Journal:  J Med Chem       Date:  2004-03-25       Impact factor: 7.446

3.  Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4.

Authors:  Qian Zhao; Liying Ma; Shibo Jiang; Hong Lu; Shuwen Liu; Yuxian He; Nathan Strick; Nouri Neamati; Asim Kumar Debnath
Journal:  Virology       Date:  2005-09-01       Impact factor: 3.616

4.  Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes.

Authors:  Richard A Friesner; Robert B Murphy; Matthew P Repasky; Leah L Frye; Jeremy R Greenwood; Thomas A Halgren; Paul C Sanschagrin; Daniel T Mainz
Journal:  J Med Chem       Date:  2006-10-19       Impact factor: 7.446

5.  Role of the active-site solvent in the thermodynamics of factor Xa ligand binding.

Authors:  Robert Abel; Tom Young; Ramy Farid; Bruce J Berne; Richard A Friesner
Journal:  J Am Chem Soc       Date:  2008-02-12       Impact factor: 15.419

6.  CD4 mimics as HIV entry inhibitors: lead optimization studies of the aromatic substituents.

Authors:  Tetsuo Narumi; Hiroshi Arai; Kazuhisa Yoshimura; Shigeyoshi Harada; Yuki Hirota; Nami Ohashi; Chie Hashimoto; Wataru Nomura; Shuzo Matsushita; Hirokazu Tamamura
Journal:  Bioorg Med Chem       Date:  2013-03-07       Impact factor: 3.641

7.  Small-Molecule CD4 Mimics Containing Mono-cyclohexyl Moieties as HIV Entry Inhibitors.

Authors:  Nami Ohashi; Shigeyoshi Harada; Takaaki Mizuguchi; Yu Irahara; Yuko Yamada; Misato Kotani; Wataru Nomura; Shuzo Matsushita; Kazuhisa Yoshimura; Hirokazu Tamamura
Journal:  ChemMedChem       Date:  2016-02-17       Impact factor: 3.466

8.  Optimization of CD4/gp120 inhibitors by thermodynamic-guided alanine-scanning mutagenesis.

Authors:  Yingyun Liu; Arne Schön; Ernesto Freire
Journal:  Chem Biol Drug Des       Date:  2013-01       Impact factor: 2.817

9.  Binding mode characterization of NBD series CD4-mimetic HIV-1 entry inhibitors by X-ray structure and resistance study.

Authors:  Francesca Curreli; Young Do Kwon; Hongtao Zhang; Yongping Yang; Daniel Scacalossi; Peter D Kwong; Asim K Debnath
Journal:  Antimicrob Agents Chemother       Date:  2014-07-07       Impact factor: 5.191

Review 10.  Structure-based design, synthesis and validation of CD4-mimetic small molecule inhibitors of HIV-1 entry: conversion of a viral entry agonist to an antagonist.

Authors:  Joel R Courter; Navid Madani; Joseph Sodroski; Arne Schön; Ernesto Freire; Peter D Kwong; Wayne A Hendrickson; Irwin M Chaiken; Judith M LaLonde; Amos B Smith
Journal:  Acc Chem Res       Date:  2014-02-06       Impact factor: 22.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.